Polymer(Korea), Vol.40, No.2, 225-231, March, 2016
생체재료로서 적용을 위한 폴리케톤의 생물학적 안전성 평가
Biological Safety Evaluation of Polyketones as Biomaterials
E-mail:
초록
생체재료는 의료기기로서 임상에 적용되기 위해서는 생물학적 안전성 평가에 의한 생체적합성 확보가 필수적이다. 이번 연구에서는 폴리케톤 고분자의 생체재료로서 사용 가능성을 평가하기 위해 생물학적 안전성 평가를 실시하였다. 폴리케톤 고분자의 용출물로 고분자의 생체적합성을 판단하는 생물학적 안전성 초기실험인 세포독성, 유전독성, 피부자극성, 감작성, 전신독성 시험을 실행하였다. 모든 시험에서 폴리케톤 고분자는 독성을 유발하지 않음을 확인할 수 있었으며, 이러한 결과는 폴리케톤 고분자가 생체재료로서 생물학적 안전성이 있으며 비분해성 고분자를 대체할 수 있을 것으로 판단된다.
Biomaterials for clinical applications such as medical and implant devices require evaluation to determine their biocompatibility. This study aimed to evaluate the initial biological safety of polyketone (PK) polymers, which have potential use as biomaterials. It presents results from cytotoxicity and genotoxicity assays and tests determining the levels of skin irritation, sensitization, and acute systemic toxicity caused by PK. The PK polymers showed no cytotoxicity, genotoxicity, allergenicity, irritancy, and systemic toxicity. These results indicate that the PK polymers are potentially biological safe and could be used to replace non-degradable polymeric biomaterials.
- Jagur-Grodzinski J, React. Funct. Polym., 39(2), 99 (1999)
- Wang YX, Robertson JL, Spillman WB, Claus RO, Pharm. Res., 21, 1362 (2004)
- Griffith LG, Acta Mater., 48, 263 (2000)
- Rogero SO, Malmonge SM, Lugao AB, Ikeda TI, Miyamaru L, Cruz AS, Artif. Organs, 27, 424 (2003)
- Lim JI, Kim SI, Jung Y, Kim SH, Polym. Korea, 37(4), 411 (2013)
- Park BJ, Park JC, “Biological safety evaluation of polymers”, in Degradation of Implant Materials, Eliaz N, Editor, Springer, New York, p 463 (2012).
- Gaspar R, Duncan R, Adv. Drug Deliv. Rev., 61, 1220 (2009)
- Jacqueline MM, Fotios P, Diane JB, AAPS J., 12, 188 (2010)
- Drent E, Budzelaar PH, Chem. Rev., 96(2), 663 (1996)
- Sommazzi A, Garbassi F, Prog. Polym. Sci, 22, 1547 (1997)
- Garbassi F, Sommazzi A, Meda L, Mestroni G, Sciutto A, Polymer, 39(6-7), 1503 (1998)
- Lagarona JM, Vickersb ME, Powella AK, Davidsona NS, Polymer, 31, 3011 (2003)
- Lim MY, Kim HJ, Baek SJ, Kim KY, Lee SS, Lee JC, Carbon, 77, 366 (2014)
- ISO 10993-12 2006 Biological evaluation of medical devicesparts 12: sample preparation and reference materials, Vol. 10993-12.
- ISO 10993-5 2009 Biological evaluation of medical devicesparts5:tests for in vitro cytotoxicity, Vol. 10993-5.
- Maron DM, Ames BN, Mutat. Res., 113, 173 (1983)
- Gatehouse D, Haworth S, Cebular T, Gocke E, Kier L, Matsushima T, Melcion C, Nohmi T, Ohta T, Venitt S, Zeiger E, Mutat. Res., 312, 217 (1994)
- ISO 10993-3 2003 Biological evaluation of medical devicesparts3:tests for genotoxicity and reproductive toxicity, Vol. 10993-3.
- OECD 1986 Guideline No. 479 Genetic Toxicology: In vitro Sister Chromatid Exchange Assay in Mammalian Cells.
- OECD 2014 Guideline No. 474 Genetic Toxicology: Mammalian Erythrocyte Micronucleus Test.
- ISO 10993-10 2002 Biological evaluation of medical devicesparts10:tests for irritation and delayed-type hypersensitivity, Vol. 10993-10.
- ISO 10993-11 2006 Biological evaluation of medical devicesparts11:tests for systemic toxicity, Vol. 10993-11.
- Park JC, Park BJ, Lee DH, Suh H, Kim DG, Kwon OH, Yonsei Med. J., 43, 518 (2002)
- Zuiderduin WCJ, Vlasveld DPN, Huetink J, Gaymans RJ, Polymer, 45(11), 3765 (2004)
- Jacqueline PC, Vagin SI, Rieger B, MRS Bull., 38, 239 (2013)
- Zuiderduin WCJ, Huetink J, Gaymans RJ, Polymer, 47(16), 5880 (2006)
- Cho HS, Chung JS, Baek SJ, Choi WJ, Kim JJ, Yoon SK, Lee JC, Appl. Chem. Eng., 23(3), 339 (2012)
- Pe´rez-Foullerat D, Hild S, Mucke A, Rieger B, Macromol. Chem. Phys., 205, 374 (2004)
- Cho HS, Chung JS, Shim J, Kim JJ, Choi WJ, Lee JC, Macromol. Res., 20(7), 732 (2012)
- Zhang Y, Broekhuis AA, Picchioni F, Macromolecules, 42(6), 1906 (2009)
- Silva VV, Lameiras FS, Lobato ZI, J. Biomed. Mater. Res., 63, 583 (2002)
- Hu LX, He J, Hou L, Wang H, Li J, Xie C, Duan Z, Sun LK, Wang X, Zhu C, PLoS One, 8, e74128 (2013)